Multimodal imaging in Alzheimer's disease: validity and usefulness for early detection
Alzheimer's disease is a progressive neurodegenerative disease that typically manifests
clinically as an isolated amnestic deficit that progresses to a characteristic dementia …
clinically as an isolated amnestic deficit that progresses to a characteristic dementia …
Brain health: the importance of recognizing cognitive impairment: an IAGG consensus conference
Cognitive impairment creates significant challenges for patients, their families and friends,
and clinicians who provide their health care. Early recognition allows for diagnosis and …
and clinicians who provide their health care. Early recognition allows for diagnosis and …
[HTML][HTML] A Cochrane review on brain [18F]FDG PET in dementia: limitations and future perspectives
[18F] FDG PET is a well-established method for the evaluation of patients with suspected
Alzheimer's disease (AD) and other neurodegenerative diseases [1]. This tool has the …
Alzheimer's disease (AD) and other neurodegenerative diseases [1]. This tool has the …
[HTML][HTML] Five-year biomarker progression variability for Alzheimer's disease dementia prediction: Can a complex instrumental activities of daily living marker fill in the …
I Tarnanas, A Tsolaki, M Wiederhold… - Alzheimer's & Dementia …, 2015 - Elsevier
Introduction Biomarker progressions explain higher variability in cognitive decline than
baseline values alone. This study examines progressions of established biomarkers along …
baseline values alone. This study examines progressions of established biomarkers along …
The relationship between atrophy and hypometabolism: is it regionally dependent in dementias?
MC Rodriguez-Oroz, B Gago, P Clavero… - Current Neurology and …, 2015 - Springer
Neuronal failure leading to dementia in neurodegenerative diseases is evidenced in vivo by
functional and structural changes in the brain such as reductions of glucose consumption …
functional and structural changes in the brain such as reductions of glucose consumption …
[HTML][HTML] New perspectives in the search for reliable biomarkers in Alzheimer disease
Background and Objectives: The search for accurate biomarkers in Alzheimer Disease (AD),
on of the most devastating neurodegenerative diseases, remains essential to enable an …
on of the most devastating neurodegenerative diseases, remains essential to enable an …
[图书][B] Comparative Neuropsychology and Brain Imaging
D Emmans, A Laihinen - 2015 - books.google.com
This volume is a special commemorative publication in honour of Professor Dr. Ulrike
Halsband, from the University of Freiburg in Germany, on the occasion of her 60th birthday …
Halsband, from the University of Freiburg in Germany, on the occasion of her 60th birthday …
[图书][B] Multiple amyloid binding sites in Alzheimer brain and their interaction with synaptic and inflammatory mechanisms
R Ni - 2015 - search.proquest.com
Alzheimer's disease (AD) is the most common type of dementia. A series of pathological
changes start many years prior to the emergence of clinical symptoms. The main aims of this …
changes start many years prior to the emergence of clinical symptoms. The main aims of this …
Expediting the Discovery and Potential Translation of Theranostic Agents for Alzheimer's Disease
RA McClure - 2015 - ir.vanderbilt.edu
Alzheimer's disease (AD) is an age-dependent neurodegenerative disorder characterized
by a progressive and inexorable loss of cognitive function most likely attributable to the …
by a progressive and inexorable loss of cognitive function most likely attributable to the …